Researchers study how Metformin could treat cancer patients



Diabetes Drug May Boost Ovarian Cancer Survival

The study suggests that metformin should be evaluated in prospective trials for treating ovarian cancer given its association with improved survival.

By Kristina Fiore, MedPage Today

Don't Miss This

Sign Up for OurCancer Care and PreventionNewsletter

Thanks for signing up!You might also like these other newsletters:

MONDAY, Dec. 3, 2012 (MedPage Today) —The first-line diabetes drug metformin may have a role in ovarian cancer treatment, researchers found.

In a retrospective, case-control study, women who'd been taking metformin during their ovarian cancer treatment — primarily for type 2 diabetes — had significantly better survival than cancer patients not on the drug, reported Viji Shridhar, PhD, of the Mayo Clinic in Rochester, Minn., and colleagues online inCancer.

"Although causation could not be assessed [in a case-control study], we observed that receipt of metformin was associated with significantly better survival in ovarian cancer," they wrote. "Metformin is worthy of clinical trials in ovarian cancer."

Most of the currently available therapies in up-front and recurrent ovarian cancer have limited efficacy, the researchers said, yet it's prohibitively expensive to discover and develop new drugs.

Instead, some researchers are turning to drug repositioning, in which existing drugs are used to treat new diseases.

Metformin, a first-line agent in type 2 diabetes, has previously shown anti-cancer effects in ovarian cancer, both in vitro and in vivo, and similar observations have been made for neoplasms in the prostate, colon, pancreas, and brain.

There is also a multi-center, phase III, randomized trial testing metformin in breast cancer, the researchers said.

Because only small studies have looked at outcomes for ovarian cancer patients treated with metformin, Shridhar's group conducted a retrospective case-control study of ovarian cancer patients who were treated at the Mayo Clinic between 1995 and 2010.

A total of 72 of these women had been taking metformin for type 2 diabetes during their ovarian cancer treatment, and they were matched with 143 controls who didn't have diabetes and weren't taking metformin.

They also assessed a subset of 61 women who'd had epithelial ovarian cancer, and compared them with 178 non-diabetic controls with the same disease.

The researchers also included a diabetic control group of 103 patients who had both diabetes and epithelial ovarian cancer and were taking insulin or other diabetes drugs instead of metformin.

Overall, the mean duration of metformin intake was 2.3 years, given at doses ranging from 500 mg twice a day to 1 gram twice a day.

In the analysis of 72 cases and 143 controls, Shridhar and colleagues found that cancer cases taking metformin had significantly better 5-year disease-specific survival than controls.

After adjusting for age, year of diagnosis, body mass index (BMI), disease stage, histology, and chemotherapy, only tumor grade and taking metformin remained independent predictors of survival in this group, they reported.

In the analysis of cases and controls with epithelial ovarian cancer, those taking metformin also had significantly better 5-year survival.

And when comparing the epithelial cohort taking metformin to diabetic controls with epithelial disease, the researchers again found significantly better survival for those on metformin.

The study was limited by its retrospective nature, its small sample size, and a lack of information on patient intake of metformin before their cancer diagnosis.

Still, the authors concluded that metformin appears to be associated with better survival in ovarian cancer patients, and that the drug should be evaluated in prospective trials for treating this disease.






Video: Cancer Cells Send Signals Boosting Survival and Drug Resistance in Other Cancer Cells

Diabetes Drug May Boost Ovarian Cancer Survival
Diabetes Drug May Boost Ovarian Cancer Survival images

2019 year
2019 year - Diabetes Drug May Boost Ovarian Cancer Survival pictures

Diabetes Drug May Boost Ovarian Cancer Survival recommend
Diabetes Drug May Boost Ovarian Cancer Survival recommend photo

Diabetes Drug May Boost Ovarian Cancer Survival foto
Diabetes Drug May Boost Ovarian Cancer Survival pictures

Diabetes Drug May Boost Ovarian Cancer Survival Diabetes Drug May Boost Ovarian Cancer Survival new foto
Diabetes Drug May Boost Ovarian Cancer Survival new picture

foto Diabetes Drug May Boost Ovarian Cancer Survival
foto Diabetes Drug May Boost Ovarian Cancer Survival

Watch Diabetes Drug May Boost Ovarian Cancer Survival video
Watch Diabetes Drug May Boost Ovarian Cancer Survival video

Discussion on this topic: Diabetes Drug May Boost Ovarian Cancer Survival, diabetes-drug-may-boost-ovarian-cancer-survival/
Communication on this topic: Diabetes Drug May Boost Ovarian Cancer Survival, diabetes-drug-may-boost-ovarian-cancer-survival/ , diabetes-drug-may-boost-ovarian-cancer-survival/

Related News


First Look: Karl Lagerfeld For Macy’s
Rosacea Skin Care Routine
Summer’s Most Beautiful Lingerie Buys
Indian Spiced Pasties Recipe
Coconut Oil Benefits: 76 Genius Coconut Oil Uses for Everyday Life
The Perfect Party Shoe Pedicure According to Sophia Webster
4 Best Times To Drink Alcohol If You Don’t Want To Gain Weight
How to Wear Shoes Without Socks
How to Remove Foreign Objects from the Eye
12 Things the Maid of Honor Can’t Forget to Do the Morning of the Wedding



Date: 11.12.2018, 17:04 / Views: 41151